|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.55 CNY | -0.18% |
|
+3.70% | +15.82% |
| Jul. 10 | Keqian Biology Buys Rights for Pig, Dog Vaccines for 3.4 Million Yuan | MT |
| Jun. 25 | China Approves Wuhan Keqian Biology's Avian Flu Quadrivalent Inactivated Vaccine | MT |
| Capitalization | 7.65B 1.06B 919M 857M 794M 1.46B 91.62B 1.64B 10.39B 3.91B 42.9B 3.99B 3.91B 158B | P/E ratio 2025 * |
17.3x | P/E ratio 2026 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise value | 7.65B 1.06B 919M 857M 794M 1.46B 91.62B 1.64B 10.39B 3.91B 42.9B 3.99B 3.91B 158B | EV / Sales 2025 * |
6.8x | EV / Sales 2026 * | 5.99x |
| Free-Float |
24.25% | Yield 2025 * |
2.96% | Yield 2026 * | 2.72% |
More valuation ratios
* Estimated data
More news
| 1 day | -0.18% | ||
| 1 week | +3.70% | ||
| Current month | +6.23% | ||
| 1 month | +6.77% | ||
| 3 months | +6.77% | ||
| 6 months | +27.31% | ||
| Current year | +15.82% |
| 1 week | 15.95 |  | 16.75 |
| 1 month | 15.01 | | 16.75 |
| Current year | 12.48 | | 18.56 |
| 1 year | 11 | | 18.56 |
| 3 years | 11 | | 32 |
| 5 years | 11 | | 51.11 |
| 10 years | 11 | | 51.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mu Lin Chen
CEO | Chief Executive Officer | 37 | 2018-06-03 |
Ming Zhong
DFI | Director of Finance/CFO | 42 | 2014-08-31 |
Gao Yuan Xu
CTO | Chief Tech/Sci/R&D Officer | 49 | 2016-11-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Gai He
BRD | Director/Board Member | 59 | 2014-09-20 |
Liu Rong Fang
BRD | Director/Board Member | 56 | 2000-12-31 |
Mei Zhou Wu
BRD | Director/Board Member | 61 | 2000-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.18% | +3.70% | +22.41% | -34.33% | 1.07B | ||
| -0.02% | -3.25% | -16.35% | -12.71% | 66.79B | ||
| +0.27% | +1.54% | +17.56% | -24.35% | 7.43B | ||
| +2.27% | +1.95% | -8.31% | +7.35% | 3.71B | ||
| +0.70% | +4.84% | +2.14% | -2.46% | 3.45B | ||
| -12.57% | -9.91% | +5.53% | -7.61% | 2.33B | ||
| +1.68% | +12.63% | +63.06% | +27.11% | 1.38B | ||
| +1.01% | -2.76% | +59.05% | +50.58% | 1.21B | ||
| +4.59% | +10.50% | +21.27% | -29.59% | 1.17B | ||
| -0.37% | +2.31% | -22.22% | -36.67% | 1.09B | ||
| Average | -0.26% | +2.18% | +14.41% | -6.27% | 8.96B | |
| Weighted average by Cap. | -0.10% | -3.65% | -8.80% | -11.62% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.12B 157M 135M 126M 117M 215M 13.48B 242M 1.53B 575M 6.31B 588M 576M 23.27B | 1.28B 178M 153M 143M 133M 244M 15.3B 274M 1.73B 653M 7.16B 667M 653M 26.41B |
| Net income | 436M 60.68M 52.36M 48.83M 45.25M 83.42M 5.22B 93.6M 592M 223M 2.44B 228M 223M 9.01B | 494M 68.82M 59.39M 55.39M 51.32M 94.62M 5.92B 106M 671M 253M 2.77B 258M 253M 10.22B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
924
Sector
Pharmaceuticals
Calendar
Aug. 25
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-17 | 16.55 ¥ | -0.18% | 2,635,313 |
| 25-07-16 | 16.58 ¥ | +2.85% | 4,018,876 |
| 25-07-15 | 16.12 ¥ | -0.62% | 2,605,606 |
| 25-07-14 | 16.22 ¥ | +1.69% | 2,557,880 |
| 25-07-11 | 15.95 ¥ | -0.06% | 1,777,919 |
End-of-day quote Shanghai S.E., July 16, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.55CNY
Average target price
21.75CNY
Spread / Average Target
+31.42%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688526 Stock
Select your edition
All financial news and data tailored to specific country editions
